The preferred indicator is an injection of indocyanine green dye which is detected and quantified by causing it to fluoresce at a sensor location, for example, at the human ear. Quantification is carried out by using cardiac output procedures and where called for, the Valsalva Maneuver is monitored at a monitor/controller giving visual cues to the patient and operator as to the quality of the necessary exhalation pressure maintenance.
申请公布号
WO2010009193(A2)
申请公布日期
2010.01.21
申请号
WO2009US50630
申请日期
2009.07.15
申请人
CARDIOX CORPORATION;EGGERS, PHILIP, E.;EGGERS, ANDREW, P.;EGGERS, ERIC, A.
发明人
EGGERS, PHILIP, E.;EGGERS, ANDREW, P.;EGGERS, ERIC, A.